Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1990 Nov 1;172(5):1325–1330. doi: 10.1084/jem.172.5.1325

Suppression of developmental anomalies by maternal macrophages in mice

PMCID: PMC2188678  PMID: 2230647

Abstract

We tested whether nonspecific tumoricidal immune cells can suppress congenital malformations by killing precursor cells destined to cause such defects. Pretreatment of pregnant ICR mice with synthetic (Pyran copolymer) and biological (Bacillus Calmette-Guerin) agents significantly suppressed radiation- and chemical-induced congenital malformations (cleft palate, digit anomalies, tail anomalies, etc.). Such suppressive effects were associated with the activation of maternal macrophages by these agents, but were lost either after the disruption of activated macrophages by supersonic waves or by inhibition of their lysosomal enzyme activity with trypan blue. These results indicate that a live activated macrophage with active lysosomal enzymes can be an effector cell to suppress maldevelopment. A similar reduction by activated macrophages was observed in strain CL/Fr, which has a high spontaneous frequency of cleft lips and palates. Furthermore, Pyran-activated maternal macrophages could pass through the placenta, and enhanced urethane-induced cell killing (but not somatic mutation) in the embryo. It is likely that a maternal immunosurveillance system eliminating preteratogenic cells allows for the replacement with normal totipotent blast cells during the pregnancy to protect abnormal development.

Full Text

The Full Text of this article is available as a PDF (662.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Claas F. H., Gijbels Y., van der Velden-de Munck J., van Rood J. J. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science. 1988 Sep 30;241(4874):1815–1817. doi: 10.1126/science.3051377. [DOI] [PubMed] [Google Scholar]
  2. Gotoh H., Nomura T., Nakajima H., Hasegawa C., Sakamoto Y. Inhibiting effects of nicotinamide on urethane-induced malformations and tumors in mice. Mutat Res. 1988 May;199(1):55–63. doi: 10.1016/0027-5107(88)90230-8. [DOI] [PubMed] [Google Scholar]
  3. Hoppe P. C. Fertilizing ability of mouse sperm from different epididymal regions and after washing and centrifugation. J Exp Zool. 1975 May;192(2):219–222. doi: 10.1002/jez.1401920212. [DOI] [PubMed] [Google Scholar]
  4. Kurishita A. Histological study of cell death in digital malformations induced by 5-azacytidine: suppressive effect of caffeine. Teratology. 1989 Feb;39(2):163–172. doi: 10.1002/tera.1420390208. [DOI] [PubMed] [Google Scholar]
  5. Mirkin B. L. Maternal and fetal distribution of drugs in pregnancy. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):643–647. doi: 10.1002/cpt1973144part2643. [DOI] [PubMed] [Google Scholar]
  6. Neuhäuser-Klaus A. An approach towards to standardization of the mammalian spot test. Arch Toxicol. 1981 Nov;48(4):229–243. doi: 10.1007/BF00319651. [DOI] [PubMed] [Google Scholar]
  7. Nomura T. Comparative inhibiting effects of methylxanthines on urethan-induced tumors, malformations, and presumed somatic mutations in mice. Cancer Res. 1983 Mar;43(3):1342–1346. [PubMed] [Google Scholar]
  8. Nomura T., Enomoto T., Shibata K., Kanzaki T., Tanaka H., Hata S., Kimura S., Kusafuka T., Sobue K., Miyamoto S. Antiteratogenic effects of tumor inhibitors, caffeine, antipain, and retinoic acid in mice. Cancer Res. 1983 Nov;43(11):5156–5162. [PubMed] [Google Scholar]
  9. Nomura T., Hata S., Shibata K., Kusafuka T. Killing of preimplantation mouse embryos by main ingredients of cleansers AS and LAS. Mutat Res. 1987 Jan;190(1):25–29. doi: 10.1016/0165-7992(87)90077-7. [DOI] [PubMed] [Google Scholar]
  10. Nomura T. Similarity of the mechanism of chemical carcinogen-initiated teratogenesis and carcinogenesis in mice. Cancer Res. 1977 Apr;37(4):969–973. [PubMed] [Google Scholar]
  11. Pollack M. S., Kirkpatrick D., Kapoor N., Dupont B., O'Reilly R. J. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med. 1982 Sep 9;307(11):662–666. doi: 10.1056/NEJM198209093071106. [DOI] [PubMed] [Google Scholar]
  12. Schultz R. M., Papamatheakis J. D., Luetzeler J., Chirigos M. A. Association of macrophage activation with antitumor activity by synthetic and biological agents. Cancer Res. 1977 Sep;37(9):3338–3343. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES